• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Alkaline earth metal oxoanionic compounds Alkaline earth metal periodates

Introduction to Barium Periodate (7CI) and Its Applications

Barium periodate (7CI), with the chemical formula Ba(IO?)?, is a compound of significant interest in the field of chemistry and pharmaceutical research. The CAS number 94601-53-3 uniquely identifies this compound, facilitating its precise classification and study. This introduction delves into the properties, applications, and recent advancements involving Barium periodate (7CI), highlighting its role in modern scientific endeavors.

The compound Barium periodate (7CI) is a barium salt of periodic acid. Periodic acid, known for its oxidizing properties, forms a stable complex with barium ions when dissolved in aqueous solutions. This compound is particularly valued for its high molecular weight and stability under controlled conditions, making it suitable for various analytical and synthetic applications.

In recent years, Barium periodate (7CI) has garnered attention in the development of novel pharmaceutical agents. Its unique chemical structure allows for the synthesis of complex organic molecules through oxidation reactions. Researchers have been exploring its potential in the synthesis of heterocyclic compounds, which are prevalent in many active pharmaceutical ingredients (APIs). The ability of Barium periodate (7CI) to facilitate selective oxidation has opened new avenues in drug discovery and development.

One of the most compelling applications of Barium periodate (7CI) is in the field of biochemistry. Studies have shown that this compound can be utilized as a catalyst in enzymatic reactions, enhancing the efficiency of certain biochemical pathways. The oxidizing properties of periodic acid derivatives, such as Barium periodate (7CI), make them ideal candidates for studying redox reactions in biological systems. This has implications for understanding metabolic processes and developing targeted therapies for various diseases.

Furthermore, Barium periodate (7CI) has found utility in materials science. Its ability to form stable complexes with metals and other elements makes it a valuable tool in the synthesis of advanced materials. For instance, researchers have used Barium periodate (7CI) to create novel catalysts that exhibit enhanced performance in industrial processes. These catalysts can lead to more efficient and environmentally friendly manufacturing methods, aligning with global sustainability goals.

The pharmaceutical industry has also benefited from the use of Barium periodate (7CI) in drug formulation. Its role as an oxidizing agent has been leveraged to develop more effective drug delivery systems. By incorporating Barium periodate (7CI) into polymeric matrices, researchers have created sustained-release formulations that improve patient compliance and therapeutic outcomes. This innovation underscores the compound's versatility and importance in modern medicine.

Recent research has further expanded the applications of Barium periodate (7CI) into nanotechnology. Scientists have synthesized nanostructured materials using this compound, which exhibit unique properties due to their small size and high surface area. These nanostructures have potential applications in diagnostics, imaging, and drug delivery systems. The ability to manipulate the physical and chemical properties of these materials at the nanoscale opens up exciting possibilities for future medical advancements.

In conclusion, Barium periodate (7CI) is a multifaceted compound with significant implications across various scientific disciplines. Its role in pharmaceutical research, biochemistry, materials science, and nanotechnology highlights its versatility and importance. As research continues to uncover new applications for this compound, its impact on science and technology is likely to grow even further. The unique properties of Barium periodate (7CI), as identified by its CAS number 94601-53-3, ensure its continued relevance in shaping the future of scientific innovation.

• 13445-51-7(Periodic acid (HIO4),dihydrate (8CI,9CI))
• 13444-71-8(Periodic acid (HIO4))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)